Praeruptorin A: Multi-Targeted Angular Pyranocoumarin for Inflammation and Cancer Research

Executive Summary: Praeruptorin A is an angular pyranocoumarin isolated from Peucedanum praeruptorum Dunn, acting as a DMT1 inhibitor and NF-κB pathway suppressant (Yu et al., 2021, DOI). It downregulates MMP1 via ERK1/2 signaling, reducing hepatocellular carcinoma metastasis without cytotoxicity (Yu et al., 2021, DOI). Praeruptorin A alleviates doxorubicin-induced myocardial injury and enhances anti-tumor efficacy in vitro and in vivo at concentrations of 0.4 μM–75 μg/mL and 0.8–30 mg/kg/day, respectively (APExBIO). It repairs intestinal barrier proteins and suppresses pro-inflammatory cytokines, supporting applications in ulcerative colitis research (Sulfo-Cy5-Azide.com). The compound shows high solubility in DMSO (≥50.8 mg/mL) and ethanol (≥12.68 mg/mL, ultrasonic), but is insoluble in water.

Biological Rationale

Praeruptorin A is a natural angular pyranocoumarin (C₂₁H₂₂O₇, MW 386.40) derived from Peucedanum praeruptorum Dunn (APExBIO). The molecule targets multiple cellular pathways implicated in inflammation, cancer metastasis, and ferroptosis. Metastatic progression in cancers, especially hepatocellular carcinoma, depends on matrix metalloproteinases (MMPs) and the ERK/MAPK signaling axis (Yu et al., 2021, DOI). Aberrant DMT1 activity leads to Fe²⁺ overload and ferroptotic cell death, relevant in cardiomyopathy and intestinal injury. NF-κB and STAT-1/3 pathways mediate inflammatory cytokine expression, central to ulcerative colitis and tumor microenvironment modulation (Sulfo-Cy5-Azide.com). Praeruptorin A's multi-targeted activity addresses these key disease mechanisms.

Mechanism of Action of Praeruptorin A

• DMT1 Inhibition: Praeruptorin A suppresses DMT1-mediated Fe²⁺ uptake, reducing ferroptosis and mitigating doxorubicin-induced myocardial injury (APExBIO).
• NF-κB Pathway Inhibition: The compound blocks NF-κB activation, lowering expression of PTGS2 (COX-2), HMOX1, and pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) as shown in vitro and in mouse models (Sulfo-Cy5-Azide.com).
• ERK1/2 Signaling Modulation: Praeruptorin A downregulates MMP1 through ERK1/2 activation, thereby inhibiting migration and invasion of hepatocellular carcinoma cells (Yu et al., 2021, DOI).
• STAT-1/3 Signaling Inhibition: It blocks phosphorylation of STAT-1/3, leading to decreased pro-inflammatory and increased anti-inflammatory cytokine production (Sulfo-Cy5-Azide.com).
• Intestinal Barrier Protection: The compound repairs tight junction proteins (ZO-1, occludin, claudin-1), reducing apoptosis in colonocytes, and alleviates experimental ulcerative colitis (Sulfo-Cy5-Azide.com).

Evidence & Benchmarks

• Praeruptorin A inhibits migration and invasion of HCC cells by downregulating MMP1 through ERK1/2 pathway activation, without affecting viability at doses up to 75 μg/mL (Yu et al., 2021, DOI).
• The compound displays no significant cytotoxicity or multi-organ toxicity in vitro and in vivo at effective concentrations (Yu et al., 2021, DOI).
• PRA suppresses NF-κB-driven expression of PTGS2 and HMOX1, as well as pro-inflammatory cytokines, in colitis and inflammatory models (Sulfo-Cy5-Azide.com).
• The effective in vitro range (0.4 μM–75 μg/mL) and in vivo dosing (0.8–1.2 mg/kg/day i.p.; 30 mg/kg/day oral) are validated for anti-inflammatory and anticancer endpoints (APExBIO).
• Praeruptorin A repairs intestinal barrier proteins and reduces colonic epithelial apoptosis in ulcerative colitis models (Sulfo-Cy5-Azide.com).

This article extends the mechanistic focus of 'Praeruptorin A: Translating Multi-Targeted Mechanism into...' by providing detailed, dosage-specific evidence for ERK1/2-MMP1 modulation in HCC. It also updates 'Praeruptorin A: Mechanistic Insights and Strategic Guidan...' with new data on safety and experimental workflow parameters.

Applications, Limits & Misconceptions

Praeruptorin A is a validated research tool for:

• Hepatocellular carcinoma metastasis inhibition via ERK1/2/MMP1 axis.
• Ulcerative colitis research through NF-κB and STAT-1/3 pathway inhibition.
• Ferroptosis inhibition in cardiomyopathy models by DMT1 blockade.
• Anti-inflammatory screening targeting cytokine release and barrier protein repair.

Common Pitfalls or Misconceptions

• Praeruptorin A is insoluble in water; DMSO or ethanol (with ultrasonic treatment) is required for stock solutions (APExBIO).
• Not all cell types respond within the same effective concentration range; titration is necessary for each model.
• Praeruptorin A does not induce cytotoxicity or apoptosis at standard research doses in HCC lines, so it should not be used as a direct cytotoxic agent (Yu et al., 2021, DOI).
• Long-term storage of solutions is not recommended; compound should be stored at 4°C protected from light (APExBIO).
• Findings in animal or cell models may not directly translate to clinical efficacy.

Workflow Integration & Parameters

Praeruptorin A (SKU N2885, APExBIO) is provided as a high-purity powder. For cell culture, dissolve at ≥50.8 mg/mL in DMSO or ≥12.68 mg/mL in ethanol (ultrasonic treatment), then dilute to 0.4 μM–75 μg/mL for assays. For in vivo studies, use 0.8–1.2 mg/kg/day (i.p.) or 30 mg/kg/day (oral) in mice. Store powder at 4°C protected from light; prepare fresh solutions as needed. For pathway-specific assays (e.g., ERK1/2, NF-κB, DMT1), benchmark against known inhibitors and include appropriate vehicle controls. For best practices in cell viability and pathway targeting, see 'Praeruptorin A (SKU N2885): Reliable Solutions for Cell V...'—this guide offers troubleshooting for reproducibility and specificity that complements the present mechanistic focus.

Conclusion & Outlook

Praeruptorin A is a mechanistically validated, multi-targeted compound for research in inflammation, ulcerative colitis, cancer metastasis, and ferroptosis. Its lack of cytotoxicity within effective dose ranges, along with robust modulation of ERK1/2, NF-κB, and DMT1 pathways, supports its role as a best-in-class research tool. APExBIO provides Praeruptorin A (SKU N2885) with detailed usage and safety information (product page). Future studies may explore clinical translation, but current evidence establishes Praeruptorin A as a preferred tool for reproducible, mechanistically clear workflows in cancer biology and inflammatory disease research.